Popular
BlogNEW
CompaniesNEW
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
Roche Pharmaceutical Development and Sales Overview slide image

Roche Pharmaceutical Development and Sales Overview

PRED neuroscience development programs -2 Molecule Indication Phase # of patients Status Neuroscience NME (RG6289) NME (RG6163) Alzheimer's disease 138 FPI Q4 2021 Psychiatric disorders 84 FPI Q1 2022 selnoflast Parkinson's disease lb 48 FPI Q3 2022 (NLRP3i, RG6418) Partner: ¹Prothena; BS-Brain Shuttle Roche CT Identifier 133
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube